Matthew Gline Roivant Sciences Ltd. (ROIV) insider trading activity
Matthew Gline is CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 17.4 Million shares of ROIV, which is worth approximately $195 Million. The most recent transaction as insider was on Mar 07, 2022, when has been sold 92,324 shares (Common Shares) at a price of $5.52 per share, resulting in proceeds of $509,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
17.4M
1434.88%
3M change
1568.4%
12M change
Total Value Held
$195 Million
MG
Matthew Gline
CEO
London, X0